IQVIA Holdings Inc (IQV) Files 10-K for the Fiscal Year Ended on December 31, 2018

IQVIA Holdings Inc (NYSE:IQV) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. IQVIA Holdings Inc is an information and technology-enabled healthcare service provider to the pharmaceutical services, biotechnology, and healthcare industries. The Commercial Solutions and Research and Development Solutions generate maximum revenue. IQVIA Holdings Inc has a market cap of $28.02 billion; its shares were traded at around $141.85 with a P/E ratio of 114.40 and P/S ratio of 2.84. IQVIA Holdings Inc had annual average EBITDA growth of 14.10% over the past five years.

For the last quarter IQVIA Holdings Inc reported a revenue of $2.7 billion, compared with the revenue of $2.6 billion during the same period a year ago. For the latest fiscal year the company reported a revenue of $10.4 billion, an increase of 6.9% from last year. For the last five years IQVIA Holdings Inc had an average revenue growth rate of 17% a year.

The reported diluted earnings per share was $1.24 for the year, a decline of 78.9% from the previous year. Over the last five years IQVIA Holdings Inc had an average EPS decline of 2.4% a year. The IQVIA Holdings Inc had an operating margin of 7.77%, compared with the operating margin of 8.44% a year before. The 10-year historical median operating margin of IQVIA Holdings Inc is 9.34%. The profitability rank of the company is 6 (out of 10).

At the end of the fiscal year, IQVIA Holdings Inc has the cash and cash equivalents of $891.0 million, compared with $959.0 million in the previous year. The long term debt was $10.9 billion, compared with $10.1 billion in the previous year. The interest coverage to the debt is 2, which is not a favorable level. IQVIA Holdings Inc has a financial strength rank of 5 (out of 10).

At the current stock price of $141.85, IQVIA Holdings Inc is traded at 79.4% premium to its historical median P/S valuation band of $79.05. The P/S ratio of the stock is 2.84, while the historical median P/S ratio is 1.58. The stock gained 39.66% during the past 12 months.

Directors and Officers Recent Trades:

Director Ronald A Rittenmeyer sold 3,840 shares of IQV stock on 02/05/2019 at the average price of $130. The price of the stock has increased by 9.12% since.

For the complete 20-year historical financial data of IQV, click here.